Agile Therapeutics Company

Agile Therapeutics is pharmaceutical company developing contraceptive healthcare products for women. The company's initial product, Twirla, (levonorgestrel and ethinyl estradiol) transdermal system is a non-daily prescription contraceptive. Twirla is based on proprietary transdermal patch technology, called Skinfusion, which is designed to allow drug delivery through the skin.

Total Funding: $204,471,650
Headquarters: Princeton, New Jersey, United States
Funding Status: IPO
Employee Number: 11-50
Estimated Revenue: $1M to $10M
Last Funding Type: Post-IPO Equity
Last Funding Date: 2021-10-08
Investors Number: 11
Founded Date: 01-01-1997
Industry: Reproductive Health & Contraception